Ledger.Open graph →
SEC Form D · filed May 10, 2017

Tracon Pharmaceuticals, Inc

Offering
$21.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

William L. Larue · SAN DIEGO, CADirectorMartin L. Mattingly · SAN DIEGO, CADirectorJ. R. Twiford · SAN DIEGO, CADirectorCharles P. Theuer · SAN DIEGO, CAExec · DirectorPaul R. Walker · SAN DIEGO, CADirectorPatricia L. Bitar · SAN DIEGO, CAExecStephen R. Worland · SAN DIEGO, CADirectorJeffrey Staub · St. Louis, MODirectorDavid Chase · Seattle, WADirectorSean Schantzen · Seattle, WAExecElizabeth Gallegos · St. Louis, MODirectorNatalie A. Riley · Dexter, MODirectorScott Howard · Pownal, MEExec · DirectorMelissa Taylor · Seattle, WADirectorH C. Logan · SAN DIEGO, CAExecToby T. Rogers · DALLAS, TXDirectorWayne Joseph · Richardson, TXDirectorLaurence Barr · Cedar Hill, TXDirectorKent Wallace · Houston, TXExec · DirectorJohn J. Guinee · Andover, MAExecBrian Henry · Houston, TXDirectorRonald E. Wilhelm · New Yourk, NYDirectorH C. Logan · SAN DIEGO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗